Compound information
- Natural Products
- ZC3529820
- Molecular Formula
- C35H36N4O8
- Molecular Weight
- 640.253314112 g/mol
- Structure
-
- IUPAC Name
- benzyl N-[1,3,3-tris(benzyloxycarbonylamino)propyl]carbamate
- InChI
- InChI=1S/C35H36N4O8/c40-32(44-22-26-13-5-1-6-14-26)36-30(37-33(41)45-23-27-15-7-2-8-16-27)21-31(38-34(42)46-24-28-17-9-3-10-18-28)39-35(43)47-25-29-19-11-4-12-20-29/h1-20,30-31H,21-25H2,(H,36,40)(H,37,41)(H,38,42)(H,39,43)
- InChI Key
- KTNAJHYJONUXLU-UHFFFAOYSA-N
- SMILES
- O=C(NC(CC(NC(=O)OCc1ccccc1)NC(=O)OCc1ccccc1)NC(=O)OCc1ccccc1)OCc1ccccc1
- Source
- ZINC000150408684
Warheads
- Carbamate
-
- Carbamate
-
- Carbamate
-
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 47 | Ring Count | 4 |
Heteroatom Count | 12 | Rotatable Bond Count | 14 |
Hydrogen Bond Acceptor Count | 8 | Hydrogen Bond Donor Count | 4 |
Topological Polar Surface Area | 153.32 Å2 | LogP | 4.325 |
LogS | -5.855 | LogD | 4.653 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.04 | Pgp substrate | 0.044 |
HIA | 0.841 | F20 % | 0.959 |
F30 % | 0.0 | Caco-2 | -5.512 |
MDCK | -4.629 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.0 | PPB | 97.926 |
VD | 0.736 | Fu | 2.362 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.509 | CYP1A2 substrate | 0.643 |
CYP2A6 substrate | 0.324 | CYP2B6 substrate | 0.682 |
CYP2C19 inhibitor | 0.87 | CYP2C19 substrate | 0.602 |
CYP2C8 substrate | 0.842 | CYP2C9 inhibitor | 0.016 |
CYP2C9 substrate | 0.947 | CYP2D6 inhibitor | 0.051 |
CYP2D6 substrate | 0.991 | CYP2E1 substrate | 0.256 |
CYP3A4 inhibitor | 0.977 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.482 | CL | 2.781 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.69 | Hepatotoxicity | 1.0 |
Mutagenicity | 0.841 | Rat Oral Acute Toxicity | 0.1 |
FDAMDD | 0.832 | Skin Sensitization | 0.012 |
Carcinogenicity | 0.003 | Eye Corrosion | 0.002 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.137 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -1.659 | IGC50 | 5.842 |
LC50FM | 4.725 | LC50DM | 5.296 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.183 | NR-AR-LBD | 0.172 |
NR-AhR | 0.004 | NR-Aromatase | 0.03 |
NR-ER | 0.546 | NR-ER-LBD | 0.331 |
NR-PPAR-gamma | 0.181 | SR-ARE | 0.816 |
SR-ATAD5 | 0.492 | SR-HSE | 0.032 |
SR-MMP | 0.391 | SR-p53 | 0.023 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.